ArticleCureus2024
Efficacy of Transvaginal Surgery Using an ORIHIME Mesh With Wider Arms and Adjusted Length.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Postoperative Reduction in Postvoid Residual Urine Volume May Be Associated With Bladder Capacity Decrease Rather Than an Increase in Tidal Voided Urine Volume in Patients With Pelvic Organ Prolapse.The journal of obstetrics and gynaecology research · 2026Article
- Transvaginal Mesh Surgery Is Sufficient to Repair Pelvic Organ Prolapse Compared to Laparoscopic Sacrocolpopexy: A Propensity Score Matching Analysis.International neurourology journal · 2025Article
- Failure to Adjust Mesh Length Beneath the Bladder Is an Independent Factor of Postoperative Urinary Incontinence After Transvaginal Mesh Surgery.International neurourology journal · 2025Article
- Article
- The Presence of Preoperative Urinary Incontinence Significantly Correlates With Postoperative Urinary Incontinence Following Laparoscopic Sacrocolpopexy.International neurourology journal · 2025Article
- Feasibility of pelvic organ prolapse surgery using polytetrafluoroethylene mesh ORIHIMEGynecology and pelvic medicine · 2025Review
- The International Consultation on Incontinence Questionnaire Short Form as a Substitute for 1-Hour Pad Weight Testing in the Evaluation of Urinary Incontinence in Patients With Pelvic Organ Prolapse Undergoing Surgery.International neurourology journal · 2024Article
- Prediction of Factors Contributing to Continued Voiding Dysfunction in Patients with Pelvic Organ Prolapse.Gynecology and minimally invasive therapyArticle
- The Prolapse Quality of Life Questionnaire can be Used to Assess Urinary Storage Conditions in Patients Undergoing Laparoscopic Sacrocolpopexy.Journal of mid-life healthArticle
- Comparison of Postoperative Voiding and Storage Function Following Laparoscopic Sacrocolpopexy and Transvaginal Mesh Surgery Using Nearest-neighbor Propensity Score Matching Analysis.Gynecology and minimally invasive therapyArticle
- Prolapse Quality-of-life Questionnaire is a Reliable Postoperative Outcome Assessment.Gynecology and minimally invasive therapyArticle
- The Prolapse Quality-of-life Questionnaire as a Substitute for Assessing Voiding and Storage Conditions in Patients Undergoing Transvaginal Mesh Surgery.Journal of mid-life healthArticle
- Article
- Comparison of Postoperative Urinary Storage Function Following Laparoscopic Sacrocolpopexy and Transvaginal Mesh Surgery Using Nearest-neighbor Propensity Score Matching Analysis.Journal of mid-life healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTransvaginal mesh surgery (TVM) is an effective treatment measure for pelvic organ prolapse (POP). However, the ORIHIME mesh (Kono Seisakusho, Japan, Tokyo), which has the disadvantage of poor adherence to tissues, is currently the only product available for this procedure. Our research team has previously developed a modified ORIHIME mesh with wider arms with the aim of minimizing the risk of POP recurrence. Additionally, the length of the mesh behind the anterior vaginal wall has been adjusted to prevent urinary incontinence. The current study aims to examine the efficacy of this modified mesh in minimizing postoperative complications in patients undergoing uphold-type TVM.
methodsThe data of 84 patients who underwent TVM using ORIHIME at our hospital since July 2019 were retrospectively analyzed. The patients were divided into three groups as follows: (a) normal arms (NA; arm width < 6 cm; n = 29 cases); (b) wide arms without length adjustment (WA and LA (-); arm width > 6 cm; n = 27 cases); and (c) wide arms with length adjustment (WA and LA (+); n = 28 cases). Data were collected using various questionnaires, and the residual urine volume was measured before and after surgery. Additionally, the 60-minute pad test was performed where possible, and the recurrence and complication rates were recorded.
resultsThe incidence of mesh exposure and urinary incontinence in daily life tended to be lower in the WA and LA (+) groups, although this difference was not statistically significant. The one-year postoperative POP recurrence rate, residual urine volume, International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score (OABSS), and the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score were significantly lower in the WA and LA (+) groups compared to the other groups.
conclusionUphold-type TVM using the modified ORIHIME mesh with wider arms and adjusted length was associated with better postoperative treatment outcomes compared to TVM using the traditional ORIHIME mesh.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.